N-Side

N-Side

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.5M

Overview

N-SIDE is a specialized technology provider operating at the intersection of digital health, AI, and life sciences operations. The company has established itself as a leader in clinical supply chain optimization, serving a significant portion of the top 20 global pharmaceutical companies. By leveraging its proprietary AI and digital twin technology, N-SIDE addresses critical inefficiencies in clinical trials, helping sponsors reduce waste, lower costs, and accelerate development timelines. With over two decades of experience and a track record of optimizing thousands of trials, the company operates a hybrid business model offering both software products and expert services.

Digital HealthAI / Machine Learning

Technology Platform

AI-driven forecasting, planning, and optimization platform for clinical trial supply chains, featuring digital twin simulation and an integrated ecosystem (Lighthouse) for collaborative planning.

Funding History

1
Total raised:$5.5M
Series A$5.5M

Opportunities

The growing complexity and cost of clinical trials, especially with adaptive and decentralized designs, drives demand for sophisticated AI-powered planning tools.
The industry-wide push for digital transformation and operational efficiency in life sciences creates a sustained tailwind for N-SIDE's specialized solutions.

Risk Factors

Competition from larger enterprise software suites and other niche players threatens market share.
The business faces implementation challenges in changing entrenched client workflows and relies heavily on the continued accuracy and trust in its AI algorithms.
Client concentration among large pharma firms presents a potential vulnerability.

Competitive Landscape

N-SIDE competes in the clinical trial optimization space against broad enterprise software providers like Veeva and Oracle, which offer clinical operations suites, and other specialized vendors focusing on supply chain or interactive response technology (IRT). Its differentiation lies in its deep focus on AI-driven forecasting, digital twin simulation, and a hybrid model combining software with deep domain expertise.